123 related articles for article (PubMed ID: 8615186)
1. Gene-environment interaction in parkinson's disease. The case of CYP2D6 gene polymorphism.
Landi MT; Ceroni M; Martignoni E; Bertazzi PA; Caporaso NE; Nappi G
Adv Neurol; 1996; 69():61-72. PubMed ID: 8615186
[No Abstract] [Full Text] [Related]
2. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy.
Planté-Bordeneuve V; Bandmann O; Wenning G; Quinn NP; Daniel SE; Harding AE
Mov Disord; 1995 May; 10(3):277-8. PubMed ID: 7651442
[TBL] [Abstract][Full Text] [Related]
3. Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease.
Bordet R; Broly F; Destée A; Libersa C
Adv Neurol; 1996; 69():97-100. PubMed ID: 8615190
[No Abstract] [Full Text] [Related]
4. Association between the oxidative polymorphism and early onset of Parkinson's disease.
Agúndez JA; Jiménez-Jiménez FJ; Luengo A; Bernal ML; Molina JA; Ayuso L; Vázquez A; Parra J; Duarte J; Coria F
Clin Pharmacol Ther; 1995 Mar; 57(3):291-8. PubMed ID: 7697946
[TBL] [Abstract][Full Text] [Related]
5. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease.
Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):911-3. PubMed ID: 8057112
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in Parkinson's disease.
Checkoway H; Farin FM; Costa-Mallen P; Kirchner SC; Costa LG
Neurotoxicology; 1998; 19(4-5):635-43. PubMed ID: 9745923
[TBL] [Abstract][Full Text] [Related]
7. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.
Smith CA; Gough AC; Leigh PN; Summers BA; Harding AE; Maraganore DM; Sturman SG; Schapira AH; Williams AC
Lancet; 1992 Jun; 339(8806):1375-7. PubMed ID: 1350805
[TBL] [Abstract][Full Text] [Related]
8. Familial Parkinson's disease and polymorphism at the CYP2D6 locus.
Mazzetti P; Le Guern E; Bonnet AM; Vidailhet M; Brice A; Agid Y
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):871-2. PubMed ID: 8021689
[No Abstract] [Full Text] [Related]
9. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease.
Tsuneoka Y; Matsuo Y; Iwahashi K; Takeuchi H; Ichikawa Y
J Biochem; 1993 Aug; 114(2):263-6. PubMed ID: 7903297
[TBL] [Abstract][Full Text] [Related]
10. Debrisoquine hydroxylase and Parkinson's disease.
Kondo I; Kanazawa I
Adv Neurol; 1993; 60():338-42. PubMed ID: 8420147
[TBL] [Abstract][Full Text] [Related]
11. Lack association between schizophrenia and the CYP2D6 gene polymorphisms.
Pirmohamed M; Wild MJ; Kitteringham NR; O'Brien K; Buchan IE; Back DJ; Park BK
Am J Med Genet; 1996 Apr; 67(2):236-7. PubMed ID: 8723057
[No Abstract] [Full Text] [Related]
12. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.
Elbaz A; Levecque C; Clavel J; Vidal JS; Richard F; Amouyel P; Alpérovitch A; Chartier-Harlin MC; Tzourio C
Ann Neurol; 2004 Mar; 55(3):430-4. PubMed ID: 14991823
[TBL] [Abstract][Full Text] [Related]
13. P450 enzymes and Parkinson's disease: the story so far.
Riedl AG; Watts PM; Jenner P; Marsden CD
Mov Disord; 1998 Mar; 13(2):212-20. PubMed ID: 9539332
[TBL] [Abstract][Full Text] [Related]
14. Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis.
Ray-Chaudhuri K; Smith C; Gough AC; Novak N; Chamoun V; Wolf CR; Leigh PN
J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):109. PubMed ID: 7823053
[No Abstract] [Full Text] [Related]
15. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease.
Kurth MC; Kurth JH
Am J Med Genet; 1993 Oct; 48(3):166-8. PubMed ID: 8291573
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics: Part II.
Gibaldi M
Ann Pharmacother; 1992 Feb; 26(2):255-61. PubMed ID: 1554942
[No Abstract] [Full Text] [Related]
17. A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy.
Iwahashi K; Miyatake R; Tsuneoka Y; Matsuo Y; Ichikawa Y; Hosokawa K; Sato K; Hayabara T
J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):263-4. PubMed ID: 7876880
[No Abstract] [Full Text] [Related]
18. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease.
Pang CP; Zhang J; Woo J; Chan D; Law LK; Tong SF; Kwok T; Kay R
Mov Disord; 1998 May; 13(3):529-32. PubMed ID: 9613747
[TBL] [Abstract][Full Text] [Related]
19. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis.
Christensen PM; Gøtzsche PC; Brøsen K
Pharmacogenetics; 1998 Dec; 8(6):473-9. PubMed ID: 9918130
[TBL] [Abstract][Full Text] [Related]
20. The molecular biology of xenobiotic enzymes and the predisposition to idiopathic Parkinson's disease.
Ho SL; McCann KP; Bennett P; Kapadi AL; Waring RH; Ramsden DB; Williams AC
Adv Neurol; 1996; 69():53-60. PubMed ID: 8615175
[No Abstract] [Full Text] [Related]
[Next] [New Search]
